Latest filing published 10 Aug 2021 for JELD-WEN Holding, Inc., €297k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Peter Farmakis: trading record in brief
All filings by Peter Farmakis on record concern JELD-WEN Holding, Inc., in the capacity of chief executive. In total, 19 filings cover trades dated from 2 February 2017 to 9 August 2021.
No open-market purchase appears, only 6 sales worth €3.0M. Outside the open market, there are 7 share grants and 6 option exercises. 2021 to date brings no purchases and 6 sales.
On 10 August 2021 came the latest disclosure, an option exercise for €89k in JELD-WEN Holding, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Peter Farmakis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 52,240 shares@ US$6.7470.5% of flowCommon StockSEC:0001674335-21-000092:0
- 5,336 shares@ US$28.5129.5% of flowCommon StockSEC:0001674335-21-000078:0
2 of 2 declarations
